numares HEALTH

Description

numares HEALTH develops biomarker tests that use nuclear magnetic resonance spectroscopy and machine learning to quantify serum metabolites and select diagnosis-relevant markers, supporting assessment of metabolic dysfunction in chronic kidney, liver, and cardiac diseases.

Related

• BioportoBioporto provides clinicians with NGAL biomarker tools for acute kidney injury risk assessment and diagnosis, and supplies NGAL ELISA kits…
• QruiseQruise develops physics-driven digital twin and control software for quantum computing, quantum sensing and magnetic resonance, providing…
• OphiomicsOphiomics develops diagnostic products combining artificial intelligence and genomics for precision liver medicine, helping clinicians…
• OrganOxOrganOx builds and supplies the OrganOx metra liver perfusion device platform for normothermic machine perfusion, used by clinicians to…
• ADmit THERAPEUTICSADmit THERAPEUTICS develops and commercializes MAP-AD®, an in vitro diagnostic test using mitochondrial DNA epigenetic biomarkers, NGS and…
• ComputomicsComputomics applies machine learning to genomic and bioinformatics data to produce trait discovery, predictive breeding values and…
• LUMA VISIONLUMA VISION develops imaging hardware, software and machine-learning systems for interventional cardiac imaging including an…
• IBA LifesciencesIBA Lifesciences develops research tools based on Strep-tag® technology for protein and cell isolation, providing purification and analysis…
• DDeepullDeepull develops the UllCORE BSI test and supporting instrument that perform direct-from-blood multiplex molecular detection of pathogens…